Rationale for the EUCAST clinical breakpoints

First Page		Document Content
Date: 2009-12-12 17:13:00 Bacteria Pefloxacin Moxifloxacin Norfloxacin Community-acquired pneumonia Levofloxacin Ofloxacin Streptococcus Quinolone Piperazines Chemistry Organic chemistry		Rationale for the EUCAST clinical breakpoints Add to Reading List Source URL: www.eucast.org Download Document from Source Website File Size: 621,47 KB Share Document on Facebook

	Trabajos Libres 2017 MENINGITIS POR STREPTOCOCCUS PNEUMONIAE EN LA ERA DE LA VACUNACION Título: ANTINEUMOCICCICA: REPORTE DE CASO Autor: PANDURO VALDEZ LI Co-autor: BECERRA TREJO BG; ESPINOZA OLIVA MM DocID: 1vmc2 - View Document
	Ministerio de Salud BOLETÍN VIGILANCIA DE LABORATORIO Vigilancia de Laboratorio de Streptococcus pneumoniae DocID: 1uREL - View Document
	1 Vol. 4, No. 11, NoviembreVigilancia de Enfermedad Invasora Streptococcus pneumoniae. Chile, 2007 – 2014. DocID: 1uDbc - View Document
	Invasive Group A Streptococcus SurveillanceRhode Island Department of Health Division of Preparedness, Response, Infectious Disease and Emergency Medical Services DocID: 1uiBW - View Document
	Ministerio de Salud VIGILANCIA DE LABORATORIO Comportamiento de Streptococcus pneumoniae serotipos 3 y 19 A en DocID: 1udYJ - View Document